1 |
gangliocytoma |
30.9 |
SYP ENO2 |
2 |
ganglioneuroma |
30.2 |
SYP NCAM1 ENO2 CHGA |
3 |
neurofibroma |
28.6 |
SYP MITF KIT CNP CD34 |
4 |
neuroblastoma |
28.1 |
SYP NCAM1 KIT ENO2 CHGA APP |
5 |
vulvar apocrine adenocarcinoma |
10.3 |
KRT20 ENO2 |
6 |
vaginal glandular tumor |
10.3 |
ENO2 CHGA |
7 |
gastric gastrinoma |
10.3 |
ENO2 CHGA |
8 |
middle cerebral artery infarction |
10.3 |
NCAM1 ENO2 |
9 |
nodular ganglioneuroblastoma |
10.3 |
ENO2 CHGA |
10 |
ewing sarcoma of bone |
10.3 |
ENO2 CHGA |
11 |
appendix lymphoma |
10.3 |
ENO2 CHGA |
12 |
malignant melanocytic neoplasm of the peripheral nerve sheath |
10.3 |
SYP ENO2 |
13 |
eyelid benign neoplasm |
10.3 |
KRT20 CHGA |
14 |
bile duct adenoma |
10.3 |
NCAM1 KRT20 |
15 |
penis sarcoma |
10.3 |
ENO2 CD34 |
16 |
sinonasal undifferentiated carcinoma |
10.3 |
SYP ENO2 |
17 |
angiomyoma |
10.3 |
ENO2 CD34 |
18 |
cerebral neuroblastoma |
10.3 |
SYP ENO2 |
19 |
papillary tumor of the pineal region |
10.3 |
SYP ENO2 |
20 |
intracranial primitive neuroectodermal tumor |
10.3 |
SYP ENO2 |
21 |
female urethral cancer |
10.2 |
KRT20 CHGA |
22 |
bile duct mucinous adenocarcinoma |
10.2 |
SYP ENO2 |
23 |
extraosseous ewings sarcoma-primitive neuroepithelial tumor |
10.2 |
SYP ENO2 |
24 |
nodular prostate |
10.2 |
SYP ENO2 |
25 |
pacinian tumor |
10.2 |
ENO2 CD34 |
26 |
cerebellar liponeurocytoma |
10.2 |
SYP ENO2 |
27 |
solid adenocarcinoma with mucin production |
10.2 |
NCAM1 CHGA |
28 |
lung combined type small cell carcinoma |
10.2 |
SYP NCAM1 |
29 |
papillary ependymoma |
10.2 |
SYP ENO2 |
30 |
nasal cavity benign neoplasm |
10.2 |
NCAM1 CD34 |
31 |
frontal lobe neoplasm |
10.2 |
SYP ENO2 |
32 |
hypoganglionosis |
10.2 |
SYP NCAM1 |
33 |
myoblastoma |
10.2 |
SYP ENO2 |
34 |
malignant granular cell myoblastoma |
10.2 |
ENO2 CD34 |
35 |
pineal parenchymal tumor of intermediate differentiation |
10.2 |
SYP ENO2 |
36 |
optic nerve astrocytoma |
10.2 |
SYP ENO2 |
37 |
adrenal neuroblastoma |
10.2 |
SYP ENO2 |
38 |
pulmonary artery leiomyosarcoma |
10.2 |
ENO2 CD34 |
39 |
extraskeletal ewing sarcoma |
10.2 |
SYP ENO2 |
40 |
congenital granular cell tumor |
10.2 |
ENO2 CD34 |
41 |
spinal cord oligodendroglioma |
10.2 |
SYP ENO2 |
42 |
vulvar leiomyoma |
10.2 |
NCAM1 CD34 |
43 |
krukenberg carcinoma |
10.2 |
SYP KRT20 |
44 |
clear cell ependymoma |
10.2 |
SYP ENO2 |
45 |
keratosis |
10.2 |
|
46 |
keratosis, seborrheic |
10.2 |
|
47 |
inverted follicular keratosis |
10.2 |
|
48 |
rhabdoid meningioma |
10.2 |
SYP ENO2 |
49 |
colonic lymphangioma |
10.2 |
KRT20 CD34 |
50 |
cerebrovascular benign neoplasm |
10.2 |
SYP ENO2 |
51 |
extraosseous ewing sarcoma |
10.2 |
SYP ENO2 |
52 |
cerebellum cancer |
10.2 |
SYP ENO2 |
53 |
endobronchial lipoma |
10.2 |
SYP ENO2 |
54 |
cerebellar medulloblastoma |
10.2 |
SYP ENO2 |
55 |
central nervous system primitive neuroectodermal neoplasm |
10.2 |
SYP ENO2 |
56 |
clear cell basal cell carcinoma |
10.2 |
KRT20 CHGA |
57 |
pineal gland cancer |
10.2 |
SYP ENO2 |
58 |
ependymoblastoma |
10.2 |
SYP ENO2 |
59 |
thyroid angiosarcoma |
10.2 |
KRT20 CD34 |
60 |
primary hepatic neuroendocrine carcinoma |
10.2 |
SYP CHGA |
61 |
extraosseous chondrosarcoma |
10.2 |
SYP ENO2 |
62 |
acinar cell cystadenocarcinoma |
10.2 |
SYP CHGA |
63 |
glomangioma |
10.2 |
SYP CD34 |
64 |
vulvar eccrine porocarcinoma |
10.2 |
SYP CHGA |
65 |
cervical large cell neuroendocrine carcinoma |
10.1 |
SYP CHGA |
66 |
gastrointestinal neuroendocrine benign tumor |
10.1 |
SYP CHGA |
67 |
adenoid squamous cell carcinoma |
10.1 |
KRT20 CD34 |
68 |
mixed ductal-endocrine carcinoma |
10.1 |
SYP CHGA |
69 |
scleredema adultorum |
10.1 |
NCAM1 CD34 |
70 |
breast papillary carcinoma |
10.1 |
SYP CHGA |
71 |
ovarian small cell carcinoma |
10.1 |
SYP ENO2 |
72 |
melanotic neuroectodermal tumor |
10.1 |
SYP ENO2 |
73 |
gastric neuroendocrine neoplasm |
10.1 |
SYP CHGA |
74 |
subleukemic leukemia |
10.1 |
SYP ENO2 |
75 |
askin's tumor |
10.1 |
SYP ENO2 |
76 |
pancreatic gastrinoma |
10.1 |
SYP CHGA |
77 |
gastrointestinal neuroendocrine tumor |
10.1 |
SYP CHGA |
78 |
sclerosing hepatic carcinoma |
10.1 |
CHGA CD34 |
79 |
glomangiomyoma |
10.1 |
SYP CD34 |
80 |
lung meningioma |
10.1 |
SYP CD34 |
81 |
pancreatic acinar cell adenocarcinoma |
10.1 |
SYP CHGA |
82 |
spinal cancer |
10.1 |
SYP ENO2 |
83 |
extra-adrenal pheochromocytoma |
10.1 |
SYP CHGA |
84 |
epithelioid malignant peripheral nerve sheath tumor |
10.1 |
CHGA CD34 |
85 |
neurofibrosarcoma |
10.1 |
ENO2 CD34 |
86 |
ureter transitional cell carcinoma |
10.1 |
NCAM1 ENO2 CHGA |
87 |
astroblastoma |
10.1 |
SYP ENO2 |
88 |
supratentorial primitive neuroectodermal tumor |
10.1 |
SYP NCAM1 |
89 |
lymphoepithelioma-like carcinoma |
10.1 |
KRT20 ENO2 |
90 |
bone benign neoplasm |
10.1 |
SYP ENO2 |
91 |
goblet cell carcinoid |
10.1 |
KRT20 ENO2 CHGA |
92 |
myxopapillary ependymoma |
10.1 |
SYP NCAM1 |
93 |
ganglioneuroblastoma |
10.1 |
SYP GNS ENO2 |
94 |
rare tumor |
10.0 |
|
95 |
anal neuroendocrine tumor |
10.0 |
SYP NCAM1 ENO2 |
96 |
adult xanthogranuloma |
10.0 |
MITF CD34 |
97 |
cerebellopontine angle primitive neuroectodermal tumor |
10.0 |
SYP NCAM1 ENO2 |
98 |
cerebrum cancer |
10.0 |
SYP ENO2 |
99 |
nasal cavity olfactory neuroblastoma |
10.0 |
SYP NCAM1 ENO2 |
100 |
subungual glomus tumor |
10.0 |
SYP CD34 |
101 |
adrenal medulla cancer |
10.0 |
SYP CHGA |
102 |
cerebral ventricle cancer |
10.0 |
SYP ENO2 |
103 |
bladder lateral wall cancer |
10.0 |
SYP KRT20 ENO2 |
104 |
obstructive hydrocephalus |
10.0 |
SYP ENO2 |
105 |
cystic basal cell carcinoma |
10.0 |
SYP KRT20 ENO2 |
106 |
medulloepithelioma |
10.0 |
SYP KRT20 ENO2 |
107 |
skin benign neoplasm |
10.0 |
KRT20 ENO2 CD34 |
108 |
intratubular embryonal carcinoma |
10.0 |
KRT20 KIT |
109 |
breast neuroendocrine neoplasm |
9.9 |
SYP ENO2 CHGA |
110 |
appendix carcinoid tumor |
9.9 |
SYP ENO2 CHGA |
111 |
auditory system cancer |
9.9 |
SYP ENO2 CHGA |
112 |
cauda equina neoplasm |
9.9 |
SYP ENO2 CHGA |
113 |
duodenal benign neoplasm |
9.9 |
SYP ENO2 CHGA |
114 |
ampulla of vater neoplasm |
9.9 |
SYP ENO2 CHGA |
115 |
middle ear adenoma |
9.9 |
SYP ENO2 CHGA |
116 |
carotid body cancer |
9.9 |
SYP ENO2 CHGA |
117 |
pineocytoma |
9.9 |
SYP ENO2 CHGA |
118 |
lung oat cell carcinoma |
9.9 |
SYP ENO2 CHGA |
119 |
cervix small cell carcinoma |
9.9 |
SYP ENO2 CHGA |
120 |
carcinoid tumors, intestinal |
9.9 |
SYP ENO2 CHGA |
121 |
thymus clear cell carcinoma |
9.9 |
KRT20 KIT |
122 |
carcinoid syndrome |
9.9 |
SYP ENO2 CHGA |
123 |
olfactory neuroblastoma |
9.9 |
SYP ENO2 CHGA |
124 |
granulosa cell tumor of the ovary |
9.9 |
SYP ENO2 CHGA |
125 |
pancreatoblastoma |
9.9 |
SYP CHGA |
126 |
microcystic adenoma |
9.9 |
SYP ENO2 CHGA |
127 |
pulmonary sclerosing hemangioma |
9.9 |
SYP ENO2 CHGA |
128 |
esophageal neuroendocrine tumor |
9.9 |
SYP NCAM1 CHGA |
129 |
sclerosing hemangioma |
9.9 |
SYP ENO2 CHGA |
130 |
papillary thymic adenocarcinoma |
9.9 |
SYP NCAM1 CHGA |
131 |
laryngeal neuroendocrine tumor |
9.9 |
SYP NCAM1 CHGA |
132 |
central neurocytoma |
9.9 |
SYP ENO2 CHGA |
133 |
esophageal adenoid cystic carcinoma |
9.9 |
SYP NCAM1 CHGA |
134 |
adrenal cortical adenoma |
9.9 |
SYP ENO2 CHGA |
135 |
islet cell tumor |
9.9 |
SYP ENO2 CHGA |
136 |
pulmonary large cell neuroendocrine carcinoma |
9.9 |
SYP NCAM1 CHGA |
137 |
chordoid meningioma |
9.9 |
SYP NCAM1 CHGA |
138 |
pancreatic endocrine carcinoma |
9.9 |
SYP NCAM1 CHGA |
139 |
ganglioglioma |
9.9 |
SYP ENO2 CHGA |
140 |
lung large cell carcinoma |
9.9 |
SYP NCAM1 CHGA |
141 |
vaginal tubulovillous adenoma |
9.9 |
SYP KRT20 CHGA |
142 |
primary pigmented nodular adrenocortical disease |
9.9 |
SYP NCAM1 CHGA |
143 |
endocrine organ benign neoplasm |
9.9 |
SYP ENO2 CHGA |
144 |
appendix adenocarcinoma |
9.9 |
SYP KRT20 CHGA |
145 |
vaginal adenoma |
9.9 |
SYP KRT20 CHGA |
146 |
vaginal benign neoplasm |
9.9 |
SYP KRT20 CHGA |
147 |
supratentorial cancer |
9.9 |
SYP ENO2 |
148 |
adrenal carcinoma |
9.9 |
SYP ENO2 CHGA |
149 |
peritoneal serous adenocarcinoma |
9.9 |
SYP KRT20 CHGA |
150 |
microphthalmia |
9.9 |
|
151 |
nevus, epidermal |
9.9 |
|
152 |
neurofibromatosis |
9.9 |
|
153 |
spinal cord sarcoma |
9.9 |
KIT CD34 |
154 |
gallbladder leiomyoma |
9.9 |
KIT CD34 |
155 |
dowling-degos disease 1 |
9.9 |
MITF KIT |
156 |
small intestine leiomyosarcoma |
9.9 |
KIT CD34 |
157 |
glomangiosarcoma |
9.9 |
SYP NCAM1 CD34 |
158 |
myxoid chondrosarcoma |
9.9 |
SYP CHGA |
159 |
deep leiomyoma |
9.9 |
KIT CD34 |
160 |
glomus tumor |
9.9 |
SYP ENO2 CD34 |
161 |
exophthalmos |
9.9 |
SYP ENO2 CD34 |
162 |
mucocele of appendix |
9.9 |
KIT CD34 |
163 |
chondrosarcoma, extraskeletal myxoid |
9.9 |
SYP ENO2 CD34 |
164 |
gastric liposarcoma |
9.9 |
KIT CD34 |
165 |
gallbladder leiomyosarcoma |
9.9 |
KIT CD34 |
166 |
liver leiomyoma |
9.9 |
KIT CD34 |
167 |
hemangioblastoma |
9.9 |
SYP ENO2 CD34 |
168 |
papillary carcinoma |
9.9 |
SYP KRT20 CHGA |
169 |
colon leiomyosarcoma |
9.9 |
KIT CD34 |
170 |
hypomelanosis of ito |
9.8 |
MITF KIT |
171 |
benign fibrous mesothelioma |
9.8 |
KIT CD34 |
172 |
small intestine leiomyoma |
9.8 |
KIT CD34 |
173 |
papilloma of choroid plexus |
9.8 |
SYP ENO2 |
174 |
retroperitoneal leiomyosarcoma |
9.8 |
KIT CD34 |
175 |
heart sarcoma |
9.8 |
KIT CD34 |
176 |
central epithelioid sarcoma |
9.8 |
SYP KRT20 CD34 |
177 |
vulvar proximal-type epithelioid sarcoma |
9.8 |
SYP KRT20 CD34 |
178 |
hepatic angiomyolipoma |
9.8 |
KIT CD34 |
179 |
breast malignant phyllodes tumor |
9.8 |
KIT CD34 |
180 |
sarcomatous intrahepatic cholangiocarcinoma |
9.8 |
KIT CD34 |
181 |
retroperitoneal sarcoma |
9.8 |
KIT CD34 |
182 |
gliosarcoma |
9.8 |
SYP ENO2 CD34 |
183 |
vaginal endometrial stromal sarcoma |
9.8 |
KIT CD34 |
184 |
esophagus sarcoma |
9.8 |
KIT CD34 |
185 |
clear cell meningioma |
9.8 |
SYP CHGA CD34 |
186 |
tuberous sclerosis |
9.8 |
SYP ENO2 CHGA |
187 |
tenosynovial giant cell tumor |
9.8 |
KIT CD34 |
188 |
vagina sarcoma |
9.8 |
KIT CD34 |
189 |
nodular malignant melanoma |
9.8 |
MITF KIT |
190 |
ovarian germ cell cancer |
9.8 |
SYP KIT |
191 |
dysgerminoma |
9.8 |
KRT20 KIT ENO2 |
192 |
waardenburg syndrome, type 4b |
9.8 |
MITF KIT |
193 |
heart cancer |
9.7 |
KIT CD34 |
194 |
autonomic nervous system neoplasm |
9.7 |
SYP ENO2 APP |
195 |
autonomic nervous system benign neoplasm |
9.7 |
SYP GNS ENO2 CHGA |
196 |
peripheral nervous system benign neoplasm |
9.7 |
SYP GNS ENO2 CHGA |
197 |
oligodendroglioma |
9.7 |
SYP ENO2 CNP CHGA |
198 |
binswanger's disease |
9.7 |
SYP CHGA APP |
199 |
auditory system benign neoplasm |
9.7 |
SYP NCAM1 ENO2 CHGA |
200 |
ureter small cell carcinoma |
9.7 |
SYP NCAM1 ENO2 CHGA |
201 |
gallbladder small cell carcinoma |
9.7 |
SYP NCAM1 ENO2 CHGA |
202 |
gastric small cell carcinoma |
9.7 |
SYP NCAM1 ENO2 CHGA |
203 |
sensory organ benign neoplasm |
9.7 |
SYP NCAM1 ENO2 CHGA |
204 |
subependymoma |
9.7 |
SYP NCAM1 ENO2 CHGA |
205 |
cervical neuroblastoma |
9.7 |
SYP NCAM1 ENO2 CHGA |
206 |
colon neuroendocrine neoplasm |
9.7 |
SYP NCAM1 ENO2 CHGA |
207 |
extracranial neuroblastoma |
9.7 |
SYP NCAM1 ENO2 CHGA |
208 |
pulmonary neuroendocrine tumor |
9.7 |
SYP NCAM1 ENO2 CHGA |
209 |
olfactory nerve neoplasm |
9.7 |
SYP NCAM1 ENO2 CHGA |
210 |
cranial nerve malignant neoplasm |
9.7 |
SYP NCAM1 ENO2 CHGA |
211 |
cranial nerve neoplasm |
9.7 |
SYP NCAM1 ENO2 CHGA |
212 |
subependymal giant cell astrocytoma |
9.7 |
SYP NCAM1 ENO2 CHGA |
213 |
malignant pheochromocytoma |
9.7 |
SYP NCAM1 ENO2 CHGA |
214 |
neuroma |
9.7 |
KIT ENO2 CD34 |
215 |
perineurioma |
9.7 |
NCAM1 KIT |
216 |
small cell carcinoma of the bladder |
9.7 |
SYP KRT20 ENO2 CHGA |
217 |
pineal region teratoma |
9.7 |
SYP KIT ENO2 |
218 |
horseshoe kidney |
9.7 |
SYP KRT20 ENO2 CHGA |
219 |
basaloid squamous cell carcinoma |
9.7 |
SYP KRT20 ENO2 CHGA |
220 |
cecal disease |
9.7 |
SYP CHGA |
221 |
plexiform schwannoma |
9.7 |
KIT ENO2 CD34 |
222 |
benign teratoma |
9.7 |
SYP KRT20 ENO2 CHGA |
223 |
retroperitoneal hemangiopericytoma |
9.7 |
KIT ENO2 CD34 |
224 |
breast leiomyosarcoma |
9.7 |
KIT ENO2 CD34 |
225 |
pancreatic serous cystadenocarcinoma |
9.7 |
SYP NCAM1 KRT20 CHGA |
226 |
uterus leiomyosarcoma |
9.7 |
SYP KIT ENO2 |
227 |
conventional fibrosarcoma |
9.7 |
KIT ENO2 CD34 |
228 |
mature teratoma |
9.7 |
SYP KIT ENO2 |
229 |
orbital cancer |
9.6 |
SYP NCAM1 ENO2 CD34 |
230 |
connective tissue benign neoplasm |
9.6 |
KIT ENO2 CD34 |
231 |
pick disease of brain |
9.6 |
SYP CHGA APP |
232 |
myeloid sarcoma |
9.6 |
NCAM1 KIT CD34 |
233 |
inflammatory myofibroblastic tumor |
9.6 |
KIT ENO2 CD34 |
234 |
dermatofibrosarcoma protuberans |
9.6 |
KIT ENO2 CD34 |
235 |
vulvar disease |
9.6 |
KRT20 KIT CD34 |
236 |
colorectal adenocarcinoma |
9.6 |
KRT20 KIT CHGA |
237 |
intestinal obstruction |
9.6 |
KRT20 KIT CD34 |
238 |
chromophobe renal cell carcinoma |
9.6 |
KRT20 KIT CHGA |
239 |
malignant spindle cell melanoma |
9.6 |
MITF KIT CD34 |
240 |
leukocyte disease |
9.6 |
NCAM1 KIT CD34 |
241 |
oncocytoma |
9.6 |
SYP KRT20 KIT |
242 |
perivascular epithelioid cell tumor |
9.6 |
SYP MITF KIT |
243 |
bone marrow cancer |
9.6 |
NCAM1 KIT CD34 |
244 |
respiratory system benign neoplasm |
9.6 |
SYP ENO2 CHGA CD34 |
245 |
meckel diverticulum |
9.6 |
KIT CHGA CD34 |
246 |
spindle cell carcinoma |
9.5 |
SYP ENO2 CHGA CD34 |
247 |
cardiovascular organ benign neoplasm |
9.5 |
SYP ENO2 CHGA CD34 |
248 |
adenosquamous carcinoma |
9.5 |
SYP KIT CHGA |
249 |
benign perivascular tumor |
9.5 |
SYP KIT CD34 |
250 |
pancytopenia |
9.5 |
NCAM1 KIT CD34 |
251 |
thymoma |
9.5 |
SYP KIT ENO2 |
252 |
combined t cell and b cell immunodeficiency |
9.5 |
NCAM1 KIT CD34 |
253 |
malignant teratoma |
9.4 |
SYP S100A6 KIT ENO2 |
254 |
urinary bladder small cell neuroendocrine carcinoma |
9.4 |
SYP NCAM1 KRT20 ENO2 CHGA |
255 |
ovarian large-cell neuroendocrine carcinoma |
9.4 |
SYP NCAM1 KRT20 ENO2 CHGA |
256 |
prostate neuroendocrine neoplasm |
9.4 |
SYP NCAM1 KRT20 ENO2 CHGA |
257 |
tubular adenocarcinoma |
9.4 |
SYP NCAM1 KRT20 ENO2 CHGA |
258 |
lung benign neoplasm |
9.4 |
SYP NCAM1 KRT20 ENO2 CHGA |
259 |
neuroendocrine tumor |
9.4 |
SYP NCAM1 KRT20 ENO2 CHGA |
260 |
cystic teratoma |
9.4 |
SYP KRT20 KIT ENO2 |
261 |
thymic carcinoma |
9.4 |
SYP KRT20 KIT ENO2 |
262 |
clear cell sarcoma |
9.4 |
SYP MITF KIT ENO2 |
263 |
malignant peripheral nerve sheath tumor |
9.4 |
S100A6 MITF KIT CD34 |
264 |
fibrous histiocytoma |
9.4 |
MITF KIT ENO2 CD34 |
265 |
neurilemmoma |
9.4 |
MITF KIT ENO2 CD34 |
266 |
central nervous system benign neoplasm |
9.3 |
SYP GNS ENO2 CHGA CD34 |
267 |
liver leiomyosarcoma |
9.3 |
KIT ENO2 CHGA CD34 |
268 |
small intestine benign neoplasm |
9.3 |
SYP KIT ENO2 CHGA |
269 |
lentigines |
9.3 |
MITF KIT |
270 |
laryngeal small cell carcinoma |
9.3 |
SYP NCAM1 KIT CHGA |
271 |
muscle cancer |
9.3 |
SYP KIT ENO2 CD34 |
272 |
endobronchial leiomyoma |
9.3 |
SYP KIT ENO2 CD34 |
273 |
cystadenoma |
9.3 |
SYP KRT20 KIT CHGA |
274 |
hemangiopericytoma, malignant |
9.3 |
SYP KIT ENO2 CD34 |
275 |
prostate stromal sarcoma |
9.3 |
SYP NCAM1 KIT CD34 |
276 |
retroperitoneum carcinoma |
9.2 |
SYP KRT20 KIT CD34 |
277 |
cavernous hemangioma |
9.2 |
SYP KRT20 KIT CD34 |
278 |
cardiovascular cancer |
9.2 |
SYP MITF KIT CD34 |
279 |
vascular cancer |
9.2 |
SYP MITF KIT CD34 |
280 |
cell type benign neoplasm |
9.2 |
SYP KIT CHGA CD34 |
281 |
hirschsprung disease 1 |
9.1 |
SYP NCAM1 MITF KIT ENO2 |
282 |
gastric hemangioma |
9.1 |
SYP NCAM1 KIT ENO2 CHGA |
283 |
endometrial small cell carcinoma |
9.1 |
SYP NCAM1 KIT ENO2 CHGA |
284 |
paraganglioma |
9.1 |
SYP NCAM1 KIT ENO2 CHGA |
285 |
suppression of tumorigenicity 12 |
9.1 |
SYP NCAM1 KIT ENO2 CHGA |
286 |
teratoma |
9.1 |
SYP KRT20 KIT ENO2 CHGA |
287 |
thyroid gland cancer |
9.0 |
SYP KRT20 KIT ENO2 CHGA |
288 |
skeletal muscle cancer |
9.0 |
SYP NCAM1 KIT ENO2 CD34 |
289 |
jejunal neoplasm |
9.0 |
SYP KRT20 KIT ENO2 CD34 |
290 |
wilms tumor 1 |
9.0 |
SYP NCAM1 KIT ENO2 CD34 |
291 |
basal cell carcinoma |
9.0 |
SYP NCAM1 KRT20 KIT CD34 |
292 |
hemangioma |
8.9 |
SYP KIT ENO2 CHGA CD34 |
293 |
mixed cell type cancer |
8.9 |
SYP KIT ENO2 CHGA CD34 |
294 |
glomangiomatosis |
8.9 |
SYP NCAM1 KIT CHGA CD34 |
295 |
neuroendocrine carcinoma |
8.8 |
SYP NCAM1 KRT20 KIT ENO2 CHGA |
296 |
large cell neuroendocrine carcinoma |
8.8 |
SYP NCAM1 KRT20 KIT ENO2 CHGA |
297 |
small cell carcinoma |
8.8 |
SYP NCAM1 KRT20 KIT ENO2 CHGA |
298 |
merkel cell carcinoma |
8.8 |
SYP NCAM1 KRT20 KIT ENO2 CHGA |
299 |
large cell carcinoma |
8.8 |
SYP NCAM1 KRT20 KIT ENO2 CHGA |
300 |
small cell cancer of the lung |
8.8 |
SYP NCAM1 KRT20 KIT ENO2 CHGA |
301 |
pheochromocytoma |
8.8 |
SYP NCAM1 MITF KIT ENO2 CHGA |
302 |
leber plus disease |
8.7 |
SYP NCAM1 KRT20 KIT ENO2 CD34 |
303 |
mediastinal cancer |
8.7 |
SYP NCAM1 KIT ENO2 CHGA CD34 |
304 |
gastrointestinal stromal tumor |
8.7 |
SYP NCAM1 KIT ENO2 CHGA CD34 |
305 |
ewing sarcoma |
8.7 |
SYP NCAM1 KIT ENO2 CHGA CD34 |
306 |
peripheral nervous system neoplasm |
8.6 |
SYP NCAM1 KIT ENO2 CD34 APP |